| Dr Gbolahan Damilola Oyinloye, MD, MHS | |
|
2500 E Capitol Dr, Appleton, WI 54911-8735 | |
| (920) 720-2300 | |
| (920) 720-3719 |
| Full Name | Dr Gbolahan Damilola Oyinloye |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 18 Years |
| Location | 2500 E Capitol Dr, Appleton, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255695888 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 2012018297 (Missouri) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 66497 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Marys Hospital | Rhinelander, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspirus Rhinelander And Tomahawk Hospitals And Clinics Inc | 9335059856 | 309 |
News Archive
The Indiana Biosciences Research Institute (IBRI) today announced a $1 million research grant from Cook Medical to support the next phase of growth for the Institute dedicated to discovery science and applied research leading to innovation targeting cardio-metabolic disease, diabetes, and poor nutrition.
Research shows that in cases of inflammatory joint disease, the earlier you catch the disease and suppress the immune system, the less likely a patient is to develop damaging and ongoing, chronic inflammation.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55. Building 55 is the company's large-scale state-of-the-art vaccine manufacturing facility in Lansing, Michigan.
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
› Verified 4 days ago
| Entity Name | Agnesian Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346228541 PECOS PAC ID: 1658289624 Enrollment ID: O20031104000263 |
News Archive
The Indiana Biosciences Research Institute (IBRI) today announced a $1 million research grant from Cook Medical to support the next phase of growth for the Institute dedicated to discovery science and applied research leading to innovation targeting cardio-metabolic disease, diabetes, and poor nutrition.
Research shows that in cases of inflammatory joint disease, the earlier you catch the disease and suppress the immune system, the less likely a patient is to develop damaging and ongoing, chronic inflammation.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55. Building 55 is the company's large-scale state-of-the-art vaccine manufacturing facility in Lansing, Michigan.
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
› Verified 4 days ago
| Entity Name | Ascension Medical Group-fox Valley Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730126392 PECOS PAC ID: 0244142420 Enrollment ID: O20031105000351 |
News Archive
The Indiana Biosciences Research Institute (IBRI) today announced a $1 million research grant from Cook Medical to support the next phase of growth for the Institute dedicated to discovery science and applied research leading to innovation targeting cardio-metabolic disease, diabetes, and poor nutrition.
Research shows that in cases of inflammatory joint disease, the earlier you catch the disease and suppress the immune system, the less likely a patient is to develop damaging and ongoing, chronic inflammation.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55. Building 55 is the company's large-scale state-of-the-art vaccine manufacturing facility in Lansing, Michigan.
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
› Verified 4 days ago
| Entity Name | Thedacare Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376656959 PECOS PAC ID: 1759294887 Enrollment ID: O20031106000088 |
News Archive
The Indiana Biosciences Research Institute (IBRI) today announced a $1 million research grant from Cook Medical to support the next phase of growth for the Institute dedicated to discovery science and applied research leading to innovation targeting cardio-metabolic disease, diabetes, and poor nutrition.
Research shows that in cases of inflammatory joint disease, the earlier you catch the disease and suppress the immune system, the less likely a patient is to develop damaging and ongoing, chronic inflammation.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55. Building 55 is the company's large-scale state-of-the-art vaccine manufacturing facility in Lansing, Michigan.
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
› Verified 4 days ago
| Entity Name | Aspirus Rhinelander & Tomahawk Hospitals & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144991340 PECOS PAC ID: 9335059856 Enrollment ID: O20031126000706 |
News Archive
The Indiana Biosciences Research Institute (IBRI) today announced a $1 million research grant from Cook Medical to support the next phase of growth for the Institute dedicated to discovery science and applied research leading to innovation targeting cardio-metabolic disease, diabetes, and poor nutrition.
Research shows that in cases of inflammatory joint disease, the earlier you catch the disease and suppress the immune system, the less likely a patient is to develop damaging and ongoing, chronic inflammation.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55. Building 55 is the company's large-scale state-of-the-art vaccine manufacturing facility in Lansing, Michigan.
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
› Verified 4 days ago
| Entity Name | Human Services Board Serving North Central Health Care Facility |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205944543 PECOS PAC ID: 4385617786 Enrollment ID: O20040813001207 |
News Archive
The Indiana Biosciences Research Institute (IBRI) today announced a $1 million research grant from Cook Medical to support the next phase of growth for the Institute dedicated to discovery science and applied research leading to innovation targeting cardio-metabolic disease, diabetes, and poor nutrition.
Research shows that in cases of inflammatory joint disease, the earlier you catch the disease and suppress the immune system, the less likely a patient is to develop damaging and ongoing, chronic inflammation.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55. Building 55 is the company's large-scale state-of-the-art vaccine manufacturing facility in Lansing, Michigan.
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
› Verified 4 days ago
| Entity Name | Aspirus Stevens Point Hospital & Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538112230 PECOS PAC ID: 1850358938 Enrollment ID: O20041210000558 |
News Archive
The Indiana Biosciences Research Institute (IBRI) today announced a $1 million research grant from Cook Medical to support the next phase of growth for the Institute dedicated to discovery science and applied research leading to innovation targeting cardio-metabolic disease, diabetes, and poor nutrition.
Research shows that in cases of inflammatory joint disease, the earlier you catch the disease and suppress the immune system, the less likely a patient is to develop damaging and ongoing, chronic inflammation.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55. Building 55 is the company's large-scale state-of-the-art vaccine manufacturing facility in Lansing, Michigan.
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
› Verified 4 days ago
| Entity Name | Ascension Ne Wisconsin, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407803638 PECOS PAC ID: 7719897784 Enrollment ID: O20061027000037 |
News Archive
The Indiana Biosciences Research Institute (IBRI) today announced a $1 million research grant from Cook Medical to support the next phase of growth for the Institute dedicated to discovery science and applied research leading to innovation targeting cardio-metabolic disease, diabetes, and poor nutrition.
Research shows that in cases of inflammatory joint disease, the earlier you catch the disease and suppress the immune system, the less likely a patient is to develop damaging and ongoing, chronic inflammation.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55. Building 55 is the company's large-scale state-of-the-art vaccine manufacturing facility in Lansing, Michigan.
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gbolahan Damilola Oyinloye, MD, MHS Po Box 19070, Green Bay, WI 54307-9070 Ph: (920) 496-4700 | Dr Gbolahan Damilola Oyinloye, MD, MHS 2500 E Capitol Dr, Appleton, WI 54911-8735 Ph: (920) 720-2300 |
News Archive
The Indiana Biosciences Research Institute (IBRI) today announced a $1 million research grant from Cook Medical to support the next phase of growth for the Institute dedicated to discovery science and applied research leading to innovation targeting cardio-metabolic disease, diabetes, and poor nutrition.
Research shows that in cases of inflammatory joint disease, the earlier you catch the disease and suppress the immune system, the less likely a patient is to develop damaging and ongoing, chronic inflammation.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55. Building 55 is the company's large-scale state-of-the-art vaccine manufacturing facility in Lansing, Michigan.
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
› Verified 4 days ago
Dr. Mark T. Rovick, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 444 N Westhill Blvd, Appleton, WI 54914 Phone: 920-750-7000 Fax: 920-364-2451 | |
Dr. Brian Michael Demuri, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 10 Tri Park Way, Appleton, WI 54914 Phone: 920-831-7908 | |
Dr. Padma Reddi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 10 Tri Parkway, Appleton, WI 54914 Phone: 920-831-7908 | |
David L Sovine, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1531 S Madison St, Appleton, WI 54915 Phone: 920-730-4411 | |
Dr. Herbert Martin Allen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3301 N Ballard Rd, Suite C, Appleton, WI 54911 Phone: 920-202-3954 Fax: 920-202-3964 | |
Michael J Panzer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1531 S Madison Street, #550, Appleton, WI 54915 Phone: 920-738-2700 Fax: 920-738-8051 | |
Richard B Stafford, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3301 N Ballard Rd, Suite C, Appleton, WI 54911 Phone: 920-202-3954 Fax: 920-202-3964 |